Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BIOPTIMATE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   8.2% 14.7% 8.8% 9.8% 25.2% 12.8% 15.4% 15.4%   Credit score (0-100)   31 15 28 24 2 17 13 13   Credit rating   BB BB BB BB B BB BB BB   Credit limit (kDKK)   0.0 -0.0 -0.0 -0.0 -0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   12.6 -294 -62.8 -317 -517 -4,998 0.0 0.0   EBITDA   12.6 -294 -62.8 -317 -517 -4,998 0.0 0.0   EBIT   9.3 -297 -64.6 -323 -3,139 -4,998 0.0 0.0   Pre-tax profit (PTP)   11.2 -297.6 -64.8 -324.6 -3,140.8 -4,997.3 0.0 0.0   Net earnings   13.0 -290.1 -59.5 -253.2 -3,226.3 -4,997.3 0.0 0.0   Pre-tax profit without non-rec. items   9.4 -298 -64.8 -325 -3,141 -4,997 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   10.5 7.3 5.5 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   87.9 -202 -262 -515 -3,741 -8,739 -8,790 -8,790   Interest-bearing liabilities   0.7 300 600 880 950 9,918 8,790 8,790   Balance sheet total (assets)   106 112 398 389 567 1,238 0.0 0.0   Net Debt   0.5 300 554 803 893 9,019 8,790 8,790     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   12.6 -294 -62.8 -317 -517 -4,998 0.0 0.0   Gross profit growth   0.0% 0.0% 78.6% -404.9% -63.0% -867.1% 0.0% 0.0%   Employees   1 0 0 0 0 0 0 0   Employee growth %   0.0% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   106 112 398 389 567 1,238 0 0   Balance sheet change%   9.8% 5.6% 254.4% -2.4% 45.9% 118.4% -100.0% 0.0%   Added value   12.6 -294.0 -62.8 -317.1 -3,133.8 -4,997.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -6 -6 194 -22 -2,809 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 -1.0 -2.0 -3.0 -4.0 -5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   74.3% 101.1% 102.9% 101.7% 607.5% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   9.2% -141.3% -13.3% -41.3% -120.5% -70.0% 0.0% 0.0%   ROI %   11.4% -152.9% -14.4% -43.6% -343.1% -92.0% 0.0% 0.0%   ROE %   15.9% -289.8% -23.3% -64.4% -675.4% -553.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   82.7% -64.3% -39.7% -57.0% -86.8% -87.6% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   4.0% -102.1% -882.8% -253.4% -172.8% -180.5% 0.0% 0.0%   Gearing %   0.8% -148.5% -229.2% -170.9% -25.4% -113.5% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   -27.0% 0.2% 0.0% 0.3% 0.2% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   5.2 0.3 0.3 0.2 0.1 0.1 0.0 0.0   Current Ratio   5.2 0.3 0.3 0.2 0.1 0.1 0.0 0.0   Cash and cash equivalent   0.2 0.0 45.6 76.6 57.1 899.5 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   77.4 -209.5 -464.7 -701.2 -3,741.3 -8,738.5 -4,394.8 -4,394.8   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   13 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   13 0 0 0 0 0 0 0   EBIT / employee   9 0 0 0 0 0 0 0   Net earnings / employee   13 0 0 0 0 0 0 0